OncoImmune receives FDA approval for COVID-19 clinical trial

OncoImmune receives FDA approval for COVID-19 clinical trial

Submitted by admin on April 9, 2020 - 10:29am
Source: 
Pharmaceutical Business Review
News Tags: 
OncoImmune
FDA
clincial trials
CD24Fc
COVID-19
Headline: 
OncoImmune receives FDA approval for COVID-19 clinical trial
snippet: 


OncoImmune has received a study-may-proceed letter from the FDA for its Phase III clinical trial testing the safety and efficacy of CD24Fc for the treatment of hospitalized COVID-19 patients (SAC-COVID).

Do Not Allow Advertisers to Use My Personal information